Story perspectives

New Pill Doubles Success in Helping Teens Quit Vaping

4/23/2025

28 6

Summary

Story summary

A groundbreaking study from Massachusetts General Hospital reveals that the oral pill varenicline, paired with behavioral counseling, significantly aids young people in quitting e-cigarettes. Among participants aged 16-25, an impressive 50% who took varenicline remained smoke-free for a month, compared to just 14% on a placebo. This research underscores the urgent need for effective strategies to combat the health risks of vaping among adolescents.

1 of 1

Story summary

A groundbreaking study from Massachusetts General Hospital reveals that the oral pill varenicline, paired with behavioral counseling, significantly aids young people in quitting e-cigarettes. Among participants aged 16-25, an impressive 50% who took varenicline remained smoke-free for a month, compared to just 14% on a placebo. This research underscores the urgent need for effective strategies to combat the health risks of vaping among adolescents.